Details for New Drug Application (NDA): 018771
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
The generic ingredient in LACRISERT is hydroxypropyl cellulose. There are forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydroxypropyl cellulose profile page.
Summary for 018771
Tradename: | LACRISERT |
Applicant: | Valeant Pharms Intl |
Ingredient: | hydroxypropyl cellulose |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 018771
Mechanism of Action | Demulcent Activity |
Suppliers and Packaging for NDA: 018771
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LACRISERT | hydroxypropyl cellulose | INSERT;OPHTHALMIC | 018771 | NDA | Bausch & Lomb Incorporated | 24208-800 | 24208-800-10 | 10 BLISTER PACK in 1 CARTON (24208-800-10) / 1 INSERT in 1 BLISTER PACK |
LACRISERT | hydroxypropyl cellulose | INSERT;OPHTHALMIC | 018771 | NDA | Bausch & Lomb Incorporated | 24208-800 | 24208-800-60 | 60 BLISTER PACK in 1 CARTON (24208-800-60) / 1 INSERT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INSERT;OPHTHALMIC | Strength | 5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Complete Access Available with Subscription